150 related articles for article (PubMed ID: 38342795)
21. RASD2 promotes the development and metastasis of uveal melanoma via enhancing glycolysis.
Xie M; Xin C
Biochem Biophys Res Commun; 2022 Jun; 610():92-98. PubMed ID: 35461072
[TBL] [Abstract][Full Text] [Related]
22. Prognostic and Functional Analysis of
Mei S; Li Y; Kang X
Dis Markers; 2022; 2022():4143447. PubMed ID: 35432628
[TBL] [Abstract][Full Text] [Related]
23. MiR-216b inhibits osteosarcoma cell proliferation, migration, and invasion by targeting Forkhead Box M1.
Wang W; Guo Z; Yu H; Fan L
J Cell Biochem; 2019 Apr; 120(4):5435-5443. PubMed ID: 30302807
[TBL] [Abstract][Full Text] [Related]
24. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
[TBL] [Abstract][Full Text] [Related]
25. Fork head box M1 regulates vascular endothelial growth factor-A expression to promote the angiogenesis and tumor cell growth of gallbladder cancer.
Wang RT; Miao RC; Zhang X; Yang GH; Mu YP; Zhang ZY; Qu K; Liu C
World J Gastroenterol; 2021 Feb; 27(8):692-707. PubMed ID: 33716448
[TBL] [Abstract][Full Text] [Related]
26. [Forkhead Box M1 Regulates the Proliferation,Invasion,and Drug Resistance of Gastric Cancer Cells
Ge N; Jiang YY; Pan ZP; Wan J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Oct; 45(5):713-720. PubMed ID: 37927011
[TBL] [Abstract][Full Text] [Related]
27. Identification of FOXM1 as a specific marker for triple‑negative breast cancer.
Tan Y; Wang Q; Xie Y; Qiao X; Zhang S; Wang Y; Yang Y; Zhang B
Int J Oncol; 2019 Jan; 54(1):87-97. PubMed ID: 30365046
[TBL] [Abstract][Full Text] [Related]
28. Silencing transcription factor FOXM1 represses proliferation, migration, and invasion while inducing apoptosis of liver cancer stem cells by regulating the expression of ALDH2.
Chen L; Wu M; Ji C; Yuan M; Liu C; Yin Q
IUBMB Life; 2020 Feb; 72(2):285-295. PubMed ID: 31580537
[TBL] [Abstract][Full Text] [Related]
29. Decoding tumor heterogeneity in uveal melanoma: basement membrane genes as novel biomarkers and therapeutic targets revealed by multi-omics approaches for cancer immunotherapy.
Li Y; Cai H; Yang J; Xie X; Pei S; Wu Y; Zhang J; Song G; Zhang J; Zhang Q; Chi H; Yang G
Front Pharmacol; 2023; 14():1264345. PubMed ID: 37822877
[No Abstract] [Full Text] [Related]
30. Prognostic significance of forkhead box M1 (FoxM1) expression and antitumour effect of FoxM1 inhibition in melanoma.
Ito T; Kohashi K; Yamada Y; Maekawa A; Kuda M; Furue M; Oda Y
Histopathology; 2016 Jul; 69(1):63-71. PubMed ID: 26619071
[TBL] [Abstract][Full Text] [Related]
31. TAP1, a potential immune-related prognosis biomarker with functional significance in uveal melanoma.
Zhu R; Chen YT; Wang BW; You YY; Wang XH; Xie HT; Jiang FG; Zhang MC
BMC Cancer; 2023 Feb; 23(1):146. PubMed ID: 36774490
[TBL] [Abstract][Full Text] [Related]
32. TRIM24 aggravates the progression of ovarian cancer through negatively regulating FOXM1 level.
Zhou HE; Pan SS; Han H
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10647-10656. PubMed ID: 31858531
[TBL] [Abstract][Full Text] [Related]
33. [Expression and significance of FoxM1 in esophageal squamous cell carcinoma cells in vitro and in vivo].
Gai L; Mao GX; Liu J; Huang H; Wang X; Yao NH
Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):179-84. PubMed ID: 26988822
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of
Bai L; Ren Y; Cui T
J Comput Biol; 2020 Jun; 27(6):965-974. PubMed ID: 31593490
[TBL] [Abstract][Full Text] [Related]
35. Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway.
Yu C; Chen L; Yie L; Wei L; Wen T; Liu Y; Chen H
Oncol Rep; 2015 May; 33(5):2402-10. PubMed ID: 25738652
[TBL] [Abstract][Full Text] [Related]
36. WHSC1 promotes wnt/β-catenin signaling in a FoxM1-dependent manner facilitating proliferation, invasion and epithelial-mesenchymal transition in breast cancer.
Zhang J; Lu J; Chen Y; Li H; Lin L
J Recept Signal Transduct Res; 2020 Oct; 40(5):410-418. PubMed ID: 32314642
[No Abstract] [Full Text] [Related]
37. Propofol disrupts cell carcinogenesis and aerobic glycolysis by regulating circTADA2A/miR-455-3p/FOXM1 axis in lung cancer.
Zhao H; Wei H; He J; Wang D; Li W; Wang Y; Ai Y; Yang J
Cell Cycle; 2020 Oct; 19(19):2538-2552. PubMed ID: 32857667
[TBL] [Abstract][Full Text] [Related]
38. A Novel Glycolysis-Related Signature for Predicting the Prognosis and Immune Infiltration of Uveal Melanoma.
Guo X; Yu X; Zhang Y; Luo H; Huang R; Zeng Y; Duan C; Chen C
Ophthalmic Res; 2023; 66(1):692-705. PubMed ID: 36858025
[TBL] [Abstract][Full Text] [Related]
39. The novel circCLK3/miR-320a/FoxM1 axis promotes cervical cancer progression.
Hong H; Zhu H; Zhao S; Wang K; Zhang N; Tian Y; Li Y; Wang Y; Lv X; Wei T; Liu Y; Fan S; Liu Y; Li Y; Cai A; Jin S; Qin Q; Li H
Cell Death Dis; 2019 Dec; 10(12):950. PubMed ID: 31831728
[TBL] [Abstract][Full Text] [Related]
40. Multi-omics approaches identify novel prognostic biomarkers of autophagy in uveal melanoma.
Jin W; Wu L; Hu L; Fu Y; Fan Z; Mou Y; Ma K
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16691-16703. PubMed ID: 37725244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]